Emrosi Officially Launched for Treatment of Inflammatory Rosacea
Journey Medical has announced the launch and initial prescriptions for Emrosi for the treatment inflammatory lesions of rosacea in adults.
According to a press release from the manufacturer, the minocycline hydrochloride modified-release capsule (40 mg) designed to treat inflammatory lesions of rosa...